In the News

The Situation: The BioPharma division of a global pharmaceutical company had developed and streamlined functional areas of drug development over many years and the general sense was that the primary business processes and information management was serving the business reasonably well. The larger challenge was in the secondary uses of data across white spaces of the business. Those crossfunctional consumers of information would typically be forced to aggregate and interpret data originally produced for different purposes when that information was needed downstream in the product development lifecycle.